Skip to main content
Top
Published in: The Patient - Patient-Centered Outcomes Research 2/2013

01-06-2013 | Original Research Article

Chronic Obstructive Pulmonary Disease (COPD) Patients’ Disease-Related Preferences

A Study Using Conjoint Analysis

Authors: Giovanni Pisa, Siegfried Freytag, Rainer Schandry

Published in: The Patient - Patient-Centered Outcomes Research | Issue 2/2013

Login to get access

Abstract

Background

In the management of chronic obstructive pulmonary disease (COPD), knowledge of disease attributes and preferences that are important to patients is crucial. This knowledge may support drug development and optimization of COPD management strategies.

Objective

To assess patient preferences in COPD and to use the conjoint methodology in order to propose a self-assessment tool based on patients’ preferences gained from this conjoint analysis. This tool might then be used in future observational study settings.

Methods

A two-step procedure was applied: an initial qualitative research module consisting of interviews with eight COPD patients served to assess COPD patients’ health state in-depth, their attitudes towards COPD and their information sources regarding the disease, symptomatology, unmet needs, and their preferences for future COPD medications. In the main quantitative research part of the study, 300 patients (with an average age of 55 years) from across Germany suffering from COPD (n = 225 with stage II and n = 75 with stage III COPD) participated. Each participant was presented with 15 different scenarios during the conjoint exercise. Additionally, the Clinical COPD Questionnaire (CCQ) had to be completed and attitudes towards COPD were assessed.

Results

According to the participants, the three COPD attributes of the highest relative importance were dyspnea, performance capability, and sleep quality. Frequency of administration of the medication, onset of medication, and emotional state due to COPD base medication played only a minor role. COPD symptoms were reported to have the highest impact on quality of life, according to the CCQ.

Conclusions

Our study proposes an alternative utility-based approach of a self-reported health state concept, utilizing the fact that patients with moderate to severe COPD would trade, e.g., ease of administration and onset of medication for relief from dyspnea.
Appendix
Available only for authorised users
Literature
1.
go back to reference WHO. Global surveillance, prevention and control of chronic respiratory diseases: a comprehensive approach. Geneva: World Health Organization; 2007. WHO. Global surveillance, prevention and control of chronic respiratory diseases: a comprehensive approach. Geneva: World Health Organization; 2007.
2.
go back to reference Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007;370(9589):765–73.CrossRef Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007;370(9589):765–73.CrossRef
3.
go back to reference Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3(11):e442.CrossRef Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3(11):e442.CrossRef
4.
go back to reference Mittmann N, Kuramoto L, Seung, et al. The cost of moderate and severe COPD exacerbations to the Canadian healthcare system. Respir Med. 2008;102(3):413–21.CrossRef Mittmann N, Kuramoto L, Seung, et al. The cost of moderate and severe COPD exacerbations to the Canadian healthcare system. Respir Med. 2008;102(3):413–21.CrossRef
5.
go back to reference Agh T, Inotai A, Meszaros A. Factors associated with medication adherence in patients with chronic obstructive pulmonary disease. Respiration. 2011;82(4):328–34.CrossRef Agh T, Inotai A, Meszaros A. Factors associated with medication adherence in patients with chronic obstructive pulmonary disease. Respiration. 2011;82(4):328–34.CrossRef
6.
go back to reference Dolce JJ, Crisp C, Manzella B, et al. Medication adherence patterns in chronic obstructive pulmonary disease. Chest. 1991;99(4):837–41.CrossRef Dolce JJ, Crisp C, Manzella B, et al. Medication adherence patterns in chronic obstructive pulmonary disease. Chest. 1991;99(4):837–41.CrossRef
7.
go back to reference Bosley CM, Parry DT, Cochrane GM. Patient compliance with inhaled medication: does combining beta-agonists with corticosteroids improve compliance? Eur Respir J. 1994;7(3):504–9.CrossRef Bosley CM, Parry DT, Cochrane GM. Patient compliance with inhaled medication: does combining beta-agonists with corticosteroids improve compliance? Eur Respir J. 1994;7(3):504–9.CrossRef
8.
go back to reference Lorig KR, Sobel DS, Stewart AL, et al. Evidence suggesting that a chronic disease self-management program can improve health status while reducing hospitalization: a randomized trial. Med Care. 1999;37(1):5–14.CrossRef Lorig KR, Sobel DS, Stewart AL, et al. Evidence suggesting that a chronic disease self-management program can improve health status while reducing hospitalization: a randomized trial. Med Care. 1999;37(1):5–14.CrossRef
9.
go back to reference Hyland ME, Stahl E. Asthma treatment needs: a comparison of patients’ and health care professionals’ perceptions. Clin Ther. 2004;26:2141–52.CrossRef Hyland ME, Stahl E. Asthma treatment needs: a comparison of patients’ and health care professionals’ perceptions. Clin Ther. 2004;26:2141–52.CrossRef
10.
go back to reference Ryan M. Discrete choice experiments in health care. BMJ. 2004;14(328):360–1.CrossRef Ryan M. Discrete choice experiments in health care. BMJ. 2004;14(328):360–1.CrossRef
11.
go back to reference Ryan M, Farrar S. Using conjoint analysis to elicit preferences for health care. BMJ. 2000;320(7248):1530–3.CrossRef Ryan M, Farrar S. Using conjoint analysis to elicit preferences for health care. BMJ. 2000;320(7248):1530–3.CrossRef
12.
go back to reference Haughney J, Partridge MR, Vogelmeier C, et al. Exacerbations of COPD: quantifying the patient’s perspective using discrete choice modelling. Eur Respir J. 2005;26(4):623–9.CrossRef Haughney J, Partridge MR, Vogelmeier C, et al. Exacerbations of COPD: quantifying the patient’s perspective using discrete choice modelling. Eur Respir J. 2005;26(4):623–9.CrossRef
14.
go back to reference McFadden D, Train K. Mixed MNL models for discrete response. J Appl Econ. 2000;15(5):447–70.CrossRef McFadden D, Train K. Mixed MNL models for discrete response. J Appl Econ. 2000;15(5):447–70.CrossRef
15.
go back to reference Kuhfeld WF. Marketing research methods in SAS: experimental design, choice, conjoint, and graphical techniques [SAS 9.2 ed.]. Cary (NC): SAS Institute Inc.; 2010. Kuhfeld WF. Marketing research methods in SAS: experimental design, choice, conjoint, and graphical techniques [SAS 9.2 ed.]. Cary (NC): SAS Institute Inc.; 2010.
16.
go back to reference van der Molen T, Willemse BW, Schokker S, Ten Hacken NH, Postma DS, Juniper EF. Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes. 2003;1(1):13.CrossRef van der Molen T, Willemse BW, Schokker S, Ten Hacken NH, Postma DS, Juniper EF. Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes. 2003;1(1):13.CrossRef
17.
go back to reference Ryan M, Gerard K. Using discrete choice experiments to value health care programmes: current practice and future research reflections. Appl Health Econ Health Policy. 2003;2(1):55–64.PubMed Ryan M, Gerard K. Using discrete choice experiments to value health care programmes: current practice and future research reflections. Appl Health Econ Health Policy. 2003;2(1):55–64.PubMed
18.
go back to reference Dransfield MT, Bailey W, Crater G, et al. Disease severity and symptoms among patients receiving monotherapy for COPD. Prim Care Respir J. 2011;20(1):46–53.CrossRef Dransfield MT, Bailey W, Crater G, et al. Disease severity and symptoms among patients receiving monotherapy for COPD. Prim Care Respir J. 2011;20(1):46–53.CrossRef
19.
go back to reference Kinsman RA, Yaroush RA, Fernandez E, et al. Symptoms and experiences in chronic bronchitis and emphysema. Chest. 1983;83(5):755–61.CrossRef Kinsman RA, Yaroush RA, Fernandez E, et al. Symptoms and experiences in chronic bronchitis and emphysema. Chest. 1983;83(5):755–61.CrossRef
20.
go back to reference Rutten-van Molken MP, Oostenbrink JB, Tashkin DP, et al. Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages? Chest. 2006;130(4):1117–28.CrossRef Rutten-van Molken MP, Oostenbrink JB, Tashkin DP, et al. Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages? Chest. 2006;130(4):1117–28.CrossRef
21.
go back to reference Jehn M, Schindler C, Meyer A, et al. Daily walking intensity as a predictor of quality of life in patients with COPD. Med Sci Sports Exerc. 2012;44(7):1212–8.CrossRef Jehn M, Schindler C, Meyer A, et al. Daily walking intensity as a predictor of quality of life in patients with COPD. Med Sci Sports Exerc. 2012;44(7):1212–8.CrossRef
22.
go back to reference Agusti A, Hedner J, Marin JM, et al. Night-time symptoms: a forgotten dimension of COPD. Eur Respir Rev. 2011;20(21):183–94.CrossRef Agusti A, Hedner J, Marin JM, et al. Night-time symptoms: a forgotten dimension of COPD. Eur Respir Rev. 2011;20(21):183–94.CrossRef
23.
go back to reference Partridge MR, Karlsson N, Small IR. Patient insight into the impact of chronic obstructive pulmonary disease in the morning: an internet survey. Curr Med Res Opin. 2009;15(8):2043–8.CrossRef Partridge MR, Karlsson N, Small IR. Patient insight into the impact of chronic obstructive pulmonary disease in the morning: an internet survey. Curr Med Res Opin. 2009;15(8):2043–8.CrossRef
24.
go back to reference Nunes DM, Mota RM, de Pontes Neto OL, et al. Impaired sleep reduces quality of life in chronic obstructive pulmonary disease. Lung. 2009;187(3):159–63.CrossRef Nunes DM, Mota RM, de Pontes Neto OL, et al. Impaired sleep reduces quality of life in chronic obstructive pulmonary disease. Lung. 2009;187(3):159–63.CrossRef
25.
go back to reference Jones PW, Agusti AG. Outcomes and markers in the assessment of chronic obstructive pulmonary disease. Eur Respir J. 2006;27(4):822–32.CrossRef Jones PW, Agusti AG. Outcomes and markers in the assessment of chronic obstructive pulmonary disease. Eur Respir J. 2006;27(4):822–32.CrossRef
26.
go back to reference Stege G, Vos PJ, van den Elshout FJ, et al. Sleep, hypnotics and chronic obstructive pulmonary disease. Respir Med. 2008;102(6):801–14.CrossRef Stege G, Vos PJ, van den Elshout FJ, et al. Sleep, hypnotics and chronic obstructive pulmonary disease. Respir Med. 2008;102(6):801–14.CrossRef
Metadata
Title
Chronic Obstructive Pulmonary Disease (COPD) Patients’ Disease-Related Preferences
A Study Using Conjoint Analysis
Authors
Giovanni Pisa
Siegfried Freytag
Rainer Schandry
Publication date
01-06-2013
Publisher
Springer International Publishing
Published in
The Patient - Patient-Centered Outcomes Research / Issue 2/2013
Print ISSN: 1178-1653
Electronic ISSN: 1178-1661
DOI
https://doi.org/10.1007/s40271-013-0007-2

Other articles of this Issue 2/2013

The Patient - Patient-Centered Outcomes Research 2/2013 Go to the issue